Shu En, Matsuno Hiroyuki, Akamastu Shigeru, Kanno Yosuke, Suga Hidetaka, Nakajima Keiichi, Ishisaki Akira, Takai Shinji, Kato Kanefusa, Kitajima Yasuo, Kozawa Osamu
Department of Pharmacology, Gifu University Graduate School of Medicine, Japan.
Arch Biochem Biophys. 2005 Jun 15;438(2):111-8. doi: 10.1016/j.abb.2005.04.008. Epub 2005 Apr 26.
alphaB-crystallin is the most abundant low-molecular-weight heat shock protein in heart and recent studies have demonstrated that it plays a cardioprotective role during myocardial infarction both in vivo and in vitro. On the other hand, platelet-derived growth factor (PDGF), a potent serum mitogen, has been reported to improve cardiac function after myocardial infarction. In the present study, using a mouse myocardial infarction model, we investigated whether alphaB-crystallin is phosphorylated during myocardial infarction and the implication of PDGF-BB. Phosphorylation of alphaB-crystallin at Ser-59 was time dependently induced and plasma PDGF-BB levels were concomitantly increased. Moreover, PDGF-BB-stimulated phosphorylation of alphaB-crystallin was suppressed by SB203580, a specific inhibitor of p38 mitogen-activated protein (MAP) kinase, in primary cultured cardiac myocytes. Our results indicate that PDGF-BB induces phosphorylation of alphaB-crystallin via p38 MAP kinase during myocardial infarction.